The FDA recently approved the treatment by Novo Nordisk for hemophilia A or B with inhibitors, designed to prevent or reduce ...

Up to half of obstructive sleep apnea patients taking Zepbound had no symptoms after one year of treatment, averaging 25 ...

Historically, healthcare organizations have considered the contact center to be a cost center, a communications platform for ...

Kamilia Smith, MD, FACOG, NCMP, discusses how societal stigma and cultural misconceptions about menopause, combined with widespread misinformation about treatment options, create significant barriers ...

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

Menopausal gay, lesbian and bisexual women are more likely to report recent sexual activity with less vaginal symptoms than ...

The temporary spending bill that the House and Senate approved last night will keep the federal government operating through ...

A new bill in Congress would require pass-through prices in both Medicare, and Medicaid and require transparency of PBM ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

The boxed warning follows a safety warning the FDA issued in September about the risk of liver injury from the use of Veozah ...

If approved, Molbreevi could be the first FDA-approved treatment for patients with autoimmune pulmonary alveolar proteinosis, ...

Although the primary endpoint was not met in a phase 2 study of women who used CBD before a scan, researchers say CBD does ...